News

The supplemental new drug application is based on a planned interim analysis from a phase III study of patients with relapsed or refractory multiple myeloma who had received

Curecumin is a bioresonant phytotherapeutic form of turmeric. UCLA/VA researchers found that curcumin, an active compound found in turmeric, may help the immune system clear the brain of

The FDA issued an approvable letter regarding the treatment in April 2006, stating that it would approve the drug on receipt of additional information. The advice issued did

The study was designed to evaluate the safety and efficacy of GVAX immunotherapy for pancreatic cancer. Patients that were examined had operable pancreatic cancer who received the immunotherapy

CollaRx Gentamicin is a Gentamicin-Collagen Sponge formulated and manufactured using Innocoll's proprietary CollaRx technology. Upon application to a wound the product releases the antibiotic gentamicin. According to Innocoll,

The study concluded that QR-443 was as effective in delaying the progression of cachexia when given orally as it had been shown to be when administered intra-peritoneally in

Eisai submitted the marketing authorization application for Inovelon in March 2005 to the European Medicines Agency. The drug has also received orphan status in the EU. Inovelon is

The expansion of AstraZeneca’s research facility will accommodate up to 100 additional researchers. They will join the more than 400 existing employees at the center. “Infectious disease is

In the first agreement Evotec has been chosen as Solvay’s partner for fragment-based drug discovery. Solvay will access Evotec’s proprietary fragment-based screening platform and fragment library to identify